成人创伤患者复苏性主动脉内球囊阻断术相关血管入路并发症:系统评价与荟萃分析
该系统评价与荟萃分析检索Medline、EMBASE、Scopus和CINAHL自建库至2021年10月14日的研究,纳入24篇文献、共675例接受REBOA置入的成人创伤患者。REBOA置入相关血管入路并发症发生率为8%(95%CI 5%-13%)。在校正发表年份和地理区域的事后荟萃回归中,使用较小(7-Fr)鞘管与血管入路并发症发生率降低相关(OR 0.87,95%CI 0.75-0.99,p=0.046;R²=35%;I²=48%)。作者认为该研究为成人创伤患者REBOA置入相关血管入路并发症提供了质量基准,较小鞘管尺寸可能与血管入路并发症减少相关。
要点
- 成人创伤患者REBOA置入相关血管入路并发症发生率为8%(95%CI 5%-13%),共纳入24篇文献、675例患者。
- 校正发表年份和地理区域后,使用较小(7-Fr)鞘管与血管入路并发症发生率降低相关(OR 0.87,95%CI 0.75-0.99,p=0.046)。
- 该荟萃回归模型R²=35%、I²=48%,提示鞘管尺寸仅解释部分变异,残余异质性存在。
- 作者认为本研究为成人创伤患者REBOA置入相关血管入路并发症提供了质量基准。
- 作者认为较小鞘管尺寸可能与血管入路并发症减少相关。
适用人群与场景
- 成人创伤患者,接受REBOA置入者。
- 排除标准包括:年龄15岁及以下患者、非创伤患者、未使用REBOA、非血管入路并发症及患者重复。
研究设计与关键结果
- 研究类型为系统评价与荟萃分析,检索Medline、EMBASE、Scopus和CINAHL自建库至2021年10月14日,纳入24篇文章、共675例接受REBOA置入的成人创伤患者。
- 主要结局REBOA置入相关血管入路并发症发生率为8%(95%CI 5%-13%)。
- 事后荟萃回归校正发表年份和地理区域后,使用较小(7-Fr)鞘管与血管入路并发症发生率降低相关(OR 0.87,95%CI 0.75-0.99,p=0.046;R²=35%;I²=48%)。
- 亚组分析按偏倚程度、鞘管尺寸、血管入路技术、提供者专科、地理区域和发表年份进行。
证据类型、等级与局限
- 证据类型:系统评价与荟萃分析;证据等级:Level III。
- 局限:原文未报告局限性。
对床旁实践的改变
- 作者认为本研究为成人创伤患者REBOA置入相关血管入路并发症提供了质量基准。
- 作者认为较小鞘管尺寸可能与血管入路并发症减少相关。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
BACKGROUND: Resuscitative endovascular balloon occlusion of the aorta (REBOA) is gaining popularity worldwide for managing hypotensive trauma patients. Vascular access complications related to REBOA placement have been reported, with some cases resulting in permanent morbidity. We aim to capitalize on the increase in literature to further describe and estimate the incidence of REBOA-associated vascular access complications in adult trauma patients.
METHODS: We searched Medline, EMBASE, Scopus, and CINAHL for studies reporting vascular access complications of REBOA in adult trauma patients from inception to October 14, 2021. Studies reporting data from adult trauma patients who underwent REBOA insertion were eligible. Exclusion criteria included patients 15 years and younger, nontrauma patients, non-REBOA use, non-vascular access complications and patient duplication. Study data was abstracted using the PRISMA checklist and verified independently by three reviewers. Meta-analysis of proportions was performed using a random effects model with Freeman-Turkey double-arcsine transformation. Post hoc meta-regression by year of publication, sheath-size, and geographic region was also performed. The incidence of vascular access complications from REBOA insertion was the primary outcome of interest. Subgroup analysis was performed by degree of bias, sheath size, technique of vascular access, provider specialty, geographical region, and publication year.
RESULTS: Twenty-four articles were included in the systematic review and the meta-analysis, for a total of 675 trauma patients who underwent REBOA insertion. The incidence of vascular access complications was 8% (95% confidence interval, 5%-13%). In post hoc meta-regression adjusting for year of publication and geographic region, the use of a smaller (7-Fr) sheath was associated with a decreased incidence of vascular access complications (odds ratio, 0.87; 95% confidence interval, 0.75-0.99; p = 0.046; R 2 = 35%; I 2 = 48%).
CONCLUSION: This study provides a benchmark for quality of care in terms of vascular access complications related to REBOA insertion in adult trauma patients. Smaller sheath size may be associated with a decrease in vascular access complications.
LEVEL OF EVIDENCE: Systematic Review and Meta-Analysis; Level III.
参考来源
- Shum-Tim L, Bichara-Allard S, Hopkins B, et al. Vascular access complications associated with resuscitative endovascular balloon occlusion of the aorta in adult trauma patients: A systematic review and meta-analysis. J Trauma Acute Care Surg. 2023. PMID: 37478348. doi:10.1097/TA.0000000000004109
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。